Skip to main content
Caplight Logo









Expedition Medicines

Expedition Medicines

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://expeditionmedicines.com/

Last Round

Seed

Oct 22, 2025

Total Funding Raised

$50M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Expedition Medicines is a biotechnology company that is building an AI platform to generate small molecule drugs against disease-driving proteins that have long been considered undruggable.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Application

Keywords

drug discoverybiotechnologygenerative chemistrybio-discovery platformai drug discoverysmall molecule discoverychemoproteomicsundruggable targetsquantum chemistrytherapeutic pipelinein silico drug designbioactive compoundsai biotechpre-clinical researchdrug discovery platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Expedition Medicines Comparables

Compare Expedition Medicines with similar companies based on industry and business-model similarity.

Expedition Medicines comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Empress Therapeutics
79%
Metaphore Biotechnologies
77%
Think Bioscience
76%

Expedition Medicines Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedOct 22, 2025

Key People

Founding team and executive leadership

Henry van den Bedem

CTO

Executive Team

Expedition Medicines Investors

Notable investors and investment history

Expedition Medicines investors
InvestorRounds
Flagship PioneeringSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 19, 2026

    Monthly visitors increased 82% MoM.

  • Feb 23, 2026

    Grew 21% QoQ from 38 to 46 employees.

Expedition Medicines Filings

Explore SEC and related filing metadata, where available.

Expedition Medicines filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Expedition Medicines's valuation, stock price, and market status.

Is Expedition Medicines a public or private company?

Expedition Medicines is a private company.

What is the current stock price of Expedition Medicines?

Expedition Medicines is a private company with no public stock price. No recent secondary market data is available.

How much is Expedition Medicines worth (valuation)?

Valuation information for Expedition Medicines is not publicly available.

Can I buy Expedition Medicines stock?

Expedition Medicines shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Expedition Medicines's last funding round?

Expedition Medicines's most recent funding round was Series A on October 22, 2025.

Who are the main investors in Expedition Medicines?

Key investors in Expedition Medicines include Flagship Pioneering.

Will Expedition Medicines IPO soon?

No public IPO plans have been announced for Expedition Medicines.

How can I track Expedition Medicines secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Expedition Medicines's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range41
Year Founded2022
Last FundingOct 22, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?